SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-033093
Filing Date
2020-07-23
Accepted
2020-07-22 17:39:37
Documents
13
Period of Report
2020-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kldo-8k_20200720.htm   iXBRL 8-K 40502
2 EX-10.1 kldo-ex101_7.htm EX-10.1 50760
  Complete submission text file 0001564590-20-033093.txt   227718

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kldo-20200720.xsd EX-101.SCH 5772
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kldo-20200720_lab.xml EX-101.LAB 19468
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kldo-20200720_pre.xml EX-101.PRE 11626
6 EXTRACTED XBRL INSTANCE DOCUMENT kldo-8k_20200720_htm.xml XML 3539
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38822 | Film No.: 201042215
SIC: 2836 Biological Products, (No Diagnostic Substances)